| Title |
Allergen-specific oral immunotherapy for peanut allergy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2012
|
| DOI | 10.1002/14651858.cd009014.pub2 |
| Pubmed ID | |
| Authors |
Ulugbek Nurmatov, Iris Venderbosch, Graham Devereux, F Estelle R Simons, Aziz Sheikh |
| Abstract |
Peanut allergy is one of the most common forms of food allergy encountered in clinical practice. In most cases, it does not spontaneously resolve; furthermore, it is frequently implicated in acute life-threatening reactions. The current management of peanut allergy centres on meticulous avoidance of peanuts and peanut-containing foods. Allergen-specific oral immunotherapy (OIT) for peanut allergy aims to induce desensitisation and then tolerance to peanut, and has the potential to revolutionise the management of peanut allergy. However, at present there is still considerable uncertainty about the effectiveness and safety of this approach. |
Twitter Demographics
The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 8% |
| Kyrgyzstan | 1 | 8% |
| Netherlands | 1 | 8% |
| France | 1 | 8% |
| Australia | 1 | 8% |
| Unknown | 7 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 92% |
| Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 310 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Canada | 1 | <1% |
| Slovenia | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 303 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 40 | 13% |
| Student > Bachelor | 40 | 13% |
| Researcher | 33 | 11% |
| Other | 26 | 8% |
| Student > Ph. D. Student | 25 | 8% |
| Other | 53 | 17% |
| Unknown | 93 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 34% |
| Nursing and Health Professions | 25 | 8% |
| Agricultural and Biological Sciences | 20 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 4% |
| Immunology and Microbiology | 8 | 3% |
| Other | 35 | 11% |
| Unknown | 106 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2019.
All research outputs
#970,238
of 24,384,616 outputs
Outputs from Cochrane database of systematic reviews
#2,022
of 12,905 outputs
Outputs of similar age
#5,239
of 171,469 outputs
Outputs of similar age from Cochrane database of systematic reviews
#42
of 232 outputs
Altmetric has tracked 24,384,616 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,905 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.